You are here: Industry Insights > SARS-CoV-2

News List

Research finds mutations aid Epsilon coronavirus variant evade protection from vaccines expresspharma
July 08, 2021
Three mutations in the spike protein of Epsilon variant of SARS-CoV-2 help the virus to evade the protection offered by current vaccines or past COVID-19 infection, according to a study.
Large-scale drug analysis reveals potential new COVID-19 antivirals firstwordpharma
July 05, 2021
Researchers at the Francis Crick Institute and University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19 or in preparation.
SAHPRA Authorises the CoronaVac Vaccine with Conditions firstwordpharma
July 05, 2021
The South African Health Products Regulatory Authority (SAHPRA) has authorised the CoronaVac COVID-19 vaccine, manufactured by Sinovac Life Sciences Co, and imported by Curanto Pharma (Pty) Ltd.
Mefloquine: A promising drug 'soldier' in the battle against COVID-19 worldpharmanews
July 02, 2021
Early 2020 saw the world break into what has been described as a "war-like situation": a pandemic, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the likes of which majority of the living generations across most of ...
Study finds drugs used to treat prostate cancer could help treat COVID-19 expresspharma
July 02, 2021
Research showed that treatment with the androgen-blocking drug enzalutamide reduced TMPRSS2 levels in lab cultures of human lung cells. It significantly reduced SARS-CoV-2 entry and infection in lung cells.
Pets Often Catch COVID From Owners, Study Finds drugs
July 02, 2021
Can pets get COVID-19 from their beloved owners? Yes, they can.
COVID-19 vaccine reduces severity, length, viral load for those who still get infected worldpharmanews
July 01, 2021
Individuals who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms than people who are unvaccinated, according to research that includes data from ongoing ...
16.8 Million Undiagnosed COVID-19 Cases in First Six Months in U.S. drugs
July 01, 2021
In the first six months of the COVID-19 pandemic in the United States, the overall weighted undiagnosed seropositivity estimate was 4.6 percent, according to a study published in the June 22 issue of Science Translational Medicine.
Study reveals mechanisms of increased infectivity, antibody resistance of SARS-CoV-2 variants: SARS-CoV-2 spike variants take different paths to result in a more infectious and resistant COVID virus firstwordpharma
June 30, 2021
Combining structural biology and computation, a Duke-led team of researchers has identified how multiple mutations on the SARS-CoV-2 spike protein independently create variants that are more transmissible and potentially resistant to antibodies.
Update on AZD7442 STORM CHASER Trial in Post-Exposure Prevention of Symptomatic COVID-19 drugs
June 29, 2021
AstraZeneca today announced results from the STORM CHASER trial assessing the safety and efficacy of AZD7442, a long-acting antibody (LAAB) combination, for the prevention of symptomatic COVID-19 in participants recently exposed to the SARS-CoV-2 virus.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page